Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024)

Ionis Pharmaceuticals' (IONS) quarterly Net Equity Issued and Repurchased came in at $489.1 million in Q3 2024, down 21.74% quarter-over-quarter from $625.0 million in Q2 2018.

Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends

Ionis Pharmaceuticals' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $489.1 million for Q3 2024.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $489.1 million in Q3 2024; TTM through Dec 2025 was $489.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $489.1 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased fell to $489.1 million in Q3 2024 per IONS's latest filing, from $625.0 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $489.1 million in Q3 2024 and bottomed at $489.1 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 141.90 Mn
10 Ionis Pharmaceuticals 9.35 Bn 7.43 Bn 243.11 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 489.10 Mn
Sep 30, 2024 489.10 Mn
Jun 30, 2018 625.00 Mn
Jun 30, 2018 625.00 Mn
Dec 31, 2017 71.74 Mn
Dec 31, 2017 71.74 Mn
Jun 30, 2017 -71.64 Mn
Jun 30, 2017 -71.64 Mn
Mar 31, 2017 71.64 Mn
Mar 31, 2017 71.64 Mn
Jun 30, 2013 173.30 Mn
Jun 30, 2013 173.30 Mn